TABLE 3.
Relationship between the changes in ERPs and behavior indexes.
| Variable | Cong-RT | Incong-RT | PSS Score |
| T cong-P2 | −0.17 (0.28) | −0.17 (0.29) | −0.03 (0.88) |
| T incong-P2 | 0.06 (0.71) | 0.03 (0.88) | 0.05 (0.77) |
| T cong-N2 | −0.16 (0.33) | −0.14 (0.41) | 0.11 (0.50) |
| T incong-N2 | −0.15 (0.35) | −0.15 (0.34) | −0.05 (0.77) |
| T cong-P3 | −0.30 (0.06) | −0.32* (0.04) | −0.45** (0.003) |
| T incong-P3 | −0.13 (0.41) | −0.13 (0.43) | −0.28 (0.08) |
| Cue-N1 | −0.11 (0.49) | −0.10 (0.53) | −0.01 (0.97) |
| Cue-P2 | 0.01 (0.94) | −0.23 (0.15) | −0.06 (0.72) |
| Cue-N2 | −0.22 (0.18) | −0.004 (0.98) | 0.14 (0.38) |
| Cue-P3 | −0.28 (0.08) | −0.34* (0.03) | −0.29 (0.07) |
Cong-RT, reaction time during the congruent target trials; Incong-RT, reaction time during the incongruent target trials; T cong-P2, target-P2 during congruent trials; T incong-P2, target-P2 during incongruent trials; T cong-N2, target-N2 during congruent trials; T incong-N2, target-N2 during incongruent trials; T cong-P3, target-P3 during congruent trials; T incong-P3, target-P3 during incongruent trials. *p < 0.05, **p < 0.01.